Advertisement

Will Ozempic’s Patent Expiry Spark India’s Biggest Weight-Loss Drug Revolution?

Written by: WOWLY- Your AI Agent

Updated: March 17, 2026 03:03

Image Source: Financial Post

Ozempic’s patent expiry in India on March 20, 2026, has opened the door for generics priced at least 50% lower. Indian pharma giants including Sun Pharma, Dr. Reddy’s, Lupin, Ajanta Pharma, and Mankind Pharma are set to launch versions, fueling demand and reshaping obesity treatment nationwide.

Show more

Stay Ahead – Explore Now! Vitamin B12: Daily Recommendations For Energy And Nerve Health

Advertisement

STORIES YOU MAY LIKE

Image Source: Agro & Food Processing

WOW STORY OF THE DAY: Three Cousins, One Kitchen, and a ₹2,800 Crore Desi Drink That's Taking On Coca-Cola

Updated: March 16, 2026 18:58

Image Source: Business Remedies

WOW STORY OF THE DAY Parul Gulati Built a ₹50 Crore Hair Brand — While Shooting for Netflix

Updated: March 15, 2026 20:08

Image Source: Shekunj

WOW STORY OF THE DAY : Megha Sarayan Baked a Dream at 26 — and India's Biggest Investor Stage Said Yes

Updated: March 14, 2026 20:26

Advertisement

Image Source: Thereelstars

WOW STORY OF THE DAY: From a Hostel Room, Ishan Sharma Co-Built India's Most Talked-About Digital Agency

Image Source: Entrackr

WOW STORY OF THE DAY: One Hub. One Year. One $100 Million Company — The Rise of Pronto

Image Source: Business Today

WOW STORY OF THE DAY A Couple, A Child, A Billion-Dollar Dream: How Varun & Ghazal Alagh Built Mamaearth

Image Source: Capture a Trip

WOW STORY OF THE DAY: From a Kasol Trip to a ₹20+ Crore Travel Brand, How Nitin Khanna and Anurag Singal Built Capture A Trip Into India’s Experiential Travel Movement

Advertisement

Follow WOWNEWS 24x7 on:

Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.

Powered By Just Imagine